{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32730293", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "22"}, "DateRevised": {"Year": "2020", "Month": "09", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "30"}], "Language": ["eng"], "ELocationID": ["e0236395", "10.1371/journal.pone.0236395"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "15", "Issue": "7", "PubDate": {"Year": "2020"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms.", "Pagination": {"StartPage": "e0236395", "MedlinePgn": "e0236395"}, "Abstract": {"AbstractText": ["Traditional Chinese Medicine (TCM) preparations are often extracts of single or multiple herbs containing hundreds of compounds, and hence it has been difficult to study their mechanisms of action. Compound Kushen Injection (CKI) is a complex mixture of compounds extracted from two medicinal plants and has been used in Chinese hospitals to treat cancer for over twenty years. To demonstrate that a systematic analysis of molecular changes resulting from complex mixtures of bioactives from TCM can identify a core set of differentially expressed (DE) genes and a reproducible set of candidate pathways. We used in vitro cancer models to measure the effect of CKI on cell cycle phases and apoptosis, and correlated those phenotypes with CKI induced changes in gene expression. We treated two cancer cell lines with or without CKI and assessed the resulting phenotypes by employing cell viability and proliferation assays. Based on these results, we carried out high-throughput transcriptome data analysis to identify genes and candidate pathways perturbed by CKI. We integrated these differential gene expression results with previously reported results and carried out validation of selected differentially expressed genes. CKI induced cell-cycle arrest and apoptosis in the cancer cell lines tested. In these cells CKI also altered the expression of 363 core candidate genes associated with cell cycle, apoptosis, DNA replication/repair, and various cancer pathways. Of these, 7 are clinically relevant to cancer diagnosis or therapy, 14 are cell cycle regulators, and most of these 21 candidates are downregulated by CKI. Comparison of our core candidate genes to a database of plant medicinal compounds and their effects on gene expression identified one-to-one, one-to-many and many-to-many regulatory relationships between compounds in CKI and DE genes. By identifying genes and promising candidate pathways associated with CKI treatment based on our transcriptome-based analysis, we have shown that this approach is useful for the systematic analysis of molecular changes resulting from complex mixtures of bioactives."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia."}], "LastName": "Cui", "ForeName": "Jian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia."}], "LastName": "Qu", "ForeName": "Zhipeng", "Initials": "Z"}, {"Identifier": ["0000-0002-5850-2471"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia."}], "LastName": "Harata-Lee", "ForeName": "Yuka", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia."}], "LastName": "Shen", "ForeName": "Hanyuan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia."}], "LastName": "Aung", "ForeName": "Thazin Nwe", "Initials": "TN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhendong Research Institute, Shanxi-Zhendong Pharmaceutical Co Ltd, Beijing, China."}], "LastName": "Wang", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia."}], "LastName": "Kortschak", "ForeName": "R Daniel", "Initials": "RD"}, {"Identifier": ["0000-0003-2404-5636"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia."}], "LastName": "Adelson", "ForeName": "David L", "Initials": "DL"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "IYR6K8KQ5K", "NameOfSubstance": "kushen"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Gene Expression Profiling"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Injections"}, {"QualifierName": [], "DescriptorName": "Molecular Sequence Annotation"}, {"QualifierName": ["drug therapy", "genetics", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Reproducibility of Results"}], "CoiStatement": "We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. While a generous donation was used to set up the Zhendong Centre by Shanxi Zhendong Pharmaceutical Co Ltd, This does not alter our adherence to PLOS ONE policies on sharing data and materials. Zhendong Pharmaceutical Co Ltd did not determine the research direction for this work or influence the analysis of the data. JC: no competing interests, ZQ: no competing interests, YHL: no competing interests, HS: no competing interests, TNA: no competing interests, WW: is an employee of Zhendong Pharma seconded to Zhendong Centre to learn bioinformatics methods, RDK: no competing interests, DLA: Director of the Zhendong Centre which was set up with a generous donation from the Zhendong Pharmaceutical Co Ltd. Zhendong Pharmaceutical has had no control over these experiments, their design or analysis and have not exercised any editorial control over the manuscript."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends in pharmacological sciences. 2005;26(11):558\u2013563. 10.1016/j.tips.2005.09.006", "ArticleIdList": ["10.1016/j.tips.2005.09.006", "16185775"]}, {"Citation": "Shu G, Yang J, Zhao W, Xu C, Hong Z, Mei Z, et al. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling. Toxicology and applied pharmacology. 2014;281(2):157\u2013165. 10.1016/j.taap.2014.06.021", "ArticleIdList": ["10.1016/j.taap.2014.06.021", "24997323"]}, {"Citation": "Zhang XL, Cao MA, Pu LP, Huang SS, Gao QX, Yuan CS, et al. A novel flavonoid isolated from Sophora flavescens exhibited anti-angiogenesis activity, decreased VEGF expression and caused G0/G1 cell cycle arrest in vitro. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2013;68(5):369\u2013375.", "ArticleIdList": ["23802436"]}, {"Citation": "Wang W, You Rl, Qin Wj, Hai Ln, Fang Mj, Huang Gh, et al. Anti-tumor activities of active ingredients in Compound Kushen Injection. Acta Pharmacologica Sinica. 2015;36(6):676\u2013679. 10.1038/aps.2015.24", "ArticleIdList": ["10.1038/aps.2015.24", "PMC4594177", "25982630"]}, {"Citation": "Zhao Z, Fan H, Higgins T, Qi J, Haines D, Trivett A, et al. Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways. Cancer letters. 2014;355(2):232\u2013241. 10.1016/j.canlet.2014.08.037", "ArticleIdList": ["10.1016/j.canlet.2014.08.037", "PMC4253542", "25242356"]}, {"Citation": "Zhang LP, Jiang JK, Tam JWO, Zhang Y, Liu XS, Xu XR, et al. Effects of Matrine on proliferation and differentiation in K-562 cells. Leukemia Research. 2001;25(9):793\u2013800. 10.1016/S0145-2126(00)00145-4", "ArticleIdList": ["10.1016/S0145-2126(00)00145-4", "11489473"]}, {"Citation": "Wu C, Huang W, Guo Y, Xia P, Sun X, Pan X, et al. Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo. Molecular medicine reports. 2015;11(6):4129\u20134134. 10.3892/mmr.2015.3338", "ArticleIdList": ["10.3892/mmr.2015.3338", "PMC4394963", "25672672"]}, {"Citation": "Ninomiya M, Koketsu M. In: Minor flavonoids (chalcones, flavanones, dihydrochalcones, and aurones). Springer-Verlag; 2013. p. 1867\u20131900."}, {"Citation": "Liao CY, Lee CC, Tsai Cc, Hsueh CW, Wang CC, Chen I, et al. Novel investigations of flavonoids as chemopreventive agents for hepatocellular carcinoma. BioMed research international. 2015;2015 10.1155/2015/840542", "ArticleIdList": ["10.1155/2015/840542", "PMC4695650", "26858957"]}, {"Citation": "Wang W, You Rl, Qin Wj, Hai Ln, Fang Mj, Huang Gh, et al. Anti-tumor activities of active ingredients in Compound Kushen Injection. Acta Pharmacologica Sinica. 2015;36(6):676 10.1038/aps.2015.24", "ArticleIdList": ["10.1038/aps.2015.24", "PMC4594177", "25982630"]}, {"Citation": "Zhang JQ, Li YM, Liu T, He WT, Chen YT, Chen XH, et al. Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World journal of gastroenterology: WJG. 2010;16(34):4281 10.3748/wjg.v16.i34.4281", "ArticleIdList": ["10.3748/wjg.v16.i34.4281", "PMC2937108", "20818811"]}, {"Citation": "Yang X, Huang M, Cai J, Lv D, Lv J, Zheng S, et al. Chemical profiling of anti-hepatocellular carcinoma constituents from Caragana tangutica Maxim. by off-line semi-preparative HPLC-NMR. Natural product research. 2017;31(10):1150\u20131155. 10.1080/14786419.2016.1230118", "ArticleIdList": ["10.1080/14786419.2016.1230118", "27626111"]}, {"Citation": "Ma X, Li RS, Wang J, Huang YQ, Li PY, Wang J, et al. The therapeutic efficacy and safety of compound kushen injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: an update systematic review and meta-analysis. Frontiers in pharmacology. 2016;7 10.3389/fphar.2016.00070", "ArticleIdList": ["10.3389/fphar.2016.00070", "PMC4814457", "27065861"]}, {"Citation": "Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q, et al. Anti-tumor activities of matrine and oxymatrine: literature review. Tumor Biology. 2014;35(6):5111\u20135119. 10.1007/s13277-014-1680-z", "ArticleIdList": ["10.1007/s13277-014-1680-z", "24526416"]}, {"Citation": "Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G. Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-\u03baB signaling. Cytotechnology. 2009;59(3):219\u2013229. 10.1007/s10616-009-9225-9", "ArticleIdList": ["10.1007/s10616-009-9225-9", "PMC2774574", "19760125"]}, {"Citation": "Hao DC, Xiao PG. Network pharmacology: a Rosetta Stone for traditional Chinese medicine. Drug development research. 2014;75(5):299\u2013312. 10.1002/ddr.21214", "ArticleIdList": ["10.1002/ddr.21214", "25160070"]}, {"Citation": "Gao L, Wang Kx, Zhou Yz, Fang Js, Qin Xm, Du Gh. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation. Scientific reports. 2018;8(1):624 10.1038/s41598-017-18325-7", "ArticleIdList": ["10.1038/s41598-017-18325-7", "PMC5766629", "29330507"]}, {"Citation": "Song YN, Zhang GB, Zhang YY, Su SB. Clinical applications of omics technologies on ZHENG differentiation research in traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine. 2013;2013 10.1155/2013/989618", "ArticleIdList": ["10.1155/2013/989618", "PMC3703351", "23853666"]}, {"Citation": "Wang P, Chen Z. Traditional Chinese medicine ZHENG and Omics convergence: A systems approach to post-genomics medicine in a global world. Omics: a journal of integrative biology. 2013;17(9):451\u2013459. 10.1089/omi.2012.0057", "ArticleIdList": ["10.1089/omi.2012.0057", "23837436"]}, {"Citation": "Cui M, Li H, Hu X. Similarities between \u201cBig Data\u201d and traditional Chinese medicine information. Journal of Traditional Chinese Medicine. 2014;34(4):518\u2013522. 10.1016/S0254-6272(15)30056-X", "ArticleIdList": ["10.1016/S0254-6272(15)30056-X", "25185374"]}, {"Citation": "Cailleau R, Young R, Oliv\u00e9 M, Reeves W J Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53: 661\u2013674, 1974. 10.1093/jnci/53.3.661", "ArticleIdList": ["10.1093/jnci/53.3.661", "PMC7364228", "4412247"]}, {"Citation": "Knowles BB, Aden DP. Human hepatoma derived cell line, process for preparation thereof, and uses therefor. US Patent 4,393,133 dated Jul 12 1983."}, {"Citation": "Cui J, Qu Z, Harata-Lee Y, Aung TN, Shen H, Wang W, et al. Cell cycle, energy metabolism and DNA repair pathways in cancer cells are suppressed by Compound Kushen Injection. BMC cancer. 2019;19(1):103 10.1186/s12885-018-5230-8", "ArticleIdList": ["10.1186/s12885-018-5230-8", "PMC6345000", "30678652"]}, {"Citation": "Qu Z, Cui J, Harata-Lee Y, Aung TN, Feng Q, Raison JM, et al. Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics. Oncotarget. 2016;7(40):66003\u201366019. 10.18632/oncotarget.11788", "ArticleIdList": ["10.18632/oncotarget.11788", "PMC5323210", "27602759"]}, {"Citation": "Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Res. 2002. January 1;30(1):207\u201310. 10.1093/nar/30.1.207", "ArticleIdList": ["10.1093/nar/30.1.207", "PMC99122", "11752295"]}, {"Citation": "Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321. 10.1093/bioinformatics/bts635", "ArticleIdList": ["10.1093/bioinformatics/bts635", "PMC3530905", "23104886"]}, {"Citation": "Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14(4):R36 10.1186/gb-2013-14-4-r36", "ArticleIdList": ["10.1186/gb-2013-14-4-r36", "PMC4053844", "23618408"]}, {"Citation": "Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u2013140. 10.1093/bioinformatics/btp616", "ArticleIdList": ["10.1093/bioinformatics/btp616", "PMC2796818", "19910308"]}, {"Citation": "Kamburov A, Wierling C, Lehrach H, Herwig R. ConsensusPathDB\u2014a database for integrating human functional interaction networks. Nucleic acids research. 2008;37(suppl_1):D623\u2013D628. 10.1093/nar/gkn698", "ArticleIdList": ["10.1093/nar/gkn698", "PMC2686562", "18940869"]}, {"Citation": "Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS: a Journal of Integrative Biology. 2012;16(5):284\u2013287. 10.1089/omi.2011.0118", "ArticleIdList": ["10.1089/omi.2011.0118", "PMC3339379", "22455463"]}, {"Citation": "Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830\u20131831. 10.1093/bioinformatics/btt285", "ArticleIdList": ["10.1093/bioinformatics/btt285", "PMC3702256", "23740750"]}, {"Citation": "Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H, et al. BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. Scientific reports. 2016;6.", "ArticleIdList": ["PMC4754750", "26879404"]}, {"Citation": "Li X, Xu X, Wang J, Yu H, Wang X, Yang H, et al. A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment. PloS one. 2012;7(9):e43918 10.1371/journal.pone.0043918", "ArticleIdList": ["10.1371/journal.pone.0043918", "PMC3433480", "22962593"]}, {"Citation": "Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal, Complex Systems. 2006;1695(5):1\u20139."}, {"Citation": "Schriml LM, Arze C, Nadendla S, Chang YWW, Mazaitis M, Felix V, et al. Disease Ontology: a backbone for disease semantic integration. Nucleic acids research. 2011;40(D1):D940\u2013D946. 10.1093/nar/gkr972", "ArticleIdList": ["10.1093/nar/gkr972", "PMC3245088", "22080554"]}, {"Citation": "Anwar-Mohamed A, El-Kadi AO. Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells. Cancer letters. 2009;275(1):93\u2013101. 10.1016/j.canlet.2008.10.003", "ArticleIdList": ["10.1016/j.canlet.2008.10.003", "19013013"]}, {"Citation": "Zhou Y, Li Y, Zhou T, Zheng J, Li S, Li HB. Dietary natural products for prevention and treatment of liver cancer. Nutrients. 2016;8(3):156 10.3390/nu8030156", "ArticleIdList": ["10.3390/nu8030156", "PMC4808884", "26978396"]}, {"Citation": "Nandekar PP, Khomane K, Chaudhary V, Rathod VP, Borkar RM, Bhandi MM, et al. Identification of leads for antiproliferative activity on MDA-MB-435 human breast cancer cells through pharmacophore and CYP1A1-mediated metabolism. European journal of medicinal chemistry. 2016;115:82\u201393. 10.1016/j.ejmech.2016.02.061", "ArticleIdList": ["10.1016/j.ejmech.2016.02.061", "26994845"]}, {"Citation": "Ou C, Zhao Y, Liu JH, Zhu B, Li PZ, Zhao HL. Relationship Between Aldosterone Synthase CYP1A1 MspI Gene Polymorphism and Prostate Cancer Risk. Technology in cancer research & treatment. 2016; p. 1533034615625519.", "ArticleIdList": ["PMC5616114", "26763619"]}, {"Citation": "Mitsui Y, Chang I, Kato T, Hashimoto Y, Yamamura S, Fukuhara S, et al. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer. Oncotarget. 2016;7(31):49107 10.18632/oncotarget.9470", "ArticleIdList": ["10.18632/oncotarget.9470", "PMC5226494", "27203547"]}, {"Citation": "Piotrowska-Kempisty H, Klupczy\u0144ska A, Trzybulska D, Kulcenty K, Sulej-Suchomska AM, Kuci\u0144ska M, et al. Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3, 4, 5, 4\u2019-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells. Toxicology letters. 2017;267:59\u201366. 10.1016/j.toxlet.2016.12.018", "ArticleIdList": ["10.1016/j.toxlet.2016.12.018", "28049037"]}, {"Citation": "Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene. 2005;24(17):2899 10.1038/sj.onc.1208615", "ArticleIdList": ["10.1038/sj.onc.1208615", "15838523"]}, {"Citation": "Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. Journal of Biological Chemistry. 2007;282(4):2130\u20132134. 10.1074/jbc.C600252200", "ArticleIdList": ["10.1074/jbc.C600252200", "17135268"]}, {"Citation": "Hollern DP, Honeysett J, Cardiff RD, Andrechek ER. The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Molecular and cellular biology. 2014;34(17):3229\u20133243. 10.1128/MCB.00737-14", "ArticleIdList": ["10.1128/MCB.00737-14", "PMC4135561", "24934442"]}, {"Citation": "Zaldua N, Llavero F, Artaso A, G\u00e1lvez P, Lacerda HM, Parada LA, et al. Rac1/p21\u2010activated kinase pathway controls retinoblastoma protein phosphorylation and E2F transcription factor activation in B lymphocytes. FEBS journal. 2016;283(4):647\u2013661. 10.1111/febs.13617", "ArticleIdList": ["10.1111/febs.13617", "26663827"]}, {"Citation": "Sun H, Xu Y, Yang X, Wang W, Bai H, Shi R, et al. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/E2F transcription factor 1\u2013dependent apoptotic pathway. Hepatology. 2013;57(3):1088\u20131097. 10.1002/hep.26188", "ArticleIdList": ["10.1002/hep.26188", "PMC3594482", "23212661"]}, {"Citation": "Christensen AG, Ehmsen S, Terp MG, Batra R, Alcaraz N, Baumbach J, et al. Elucidation of Altered Pathways in Tumor\u2010Initiating Cells of Triple\u2010Negative Breast Cancer: A Useful Cell Model System for Drug Screening. STEM CELLS. 2017;.", "ArticleIdList": ["28600813"]}, {"Citation": "Zhang H, Ye Y, Li M, Ye S, Huang W, Cai T, et al. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer. Oncogene. 2016;.", "ArticleIdList": ["27721403"]}, {"Citation": "Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC, et al. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer research. 2001;61(4):1686\u20131692.", "ArticleIdList": ["11245484"]}, {"Citation": "Luo M, Guan JL. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer letters. 2010;289(2):127\u2013139. 10.1016/j.canlet.2009.07.005", "ArticleIdList": ["10.1016/j.canlet.2009.07.005", "PMC2854647", "19643531"]}, {"Citation": "Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. The Journal of clinical investigation. 1995;95(4):1789\u20131797. 10.1172/JCI117857", "ArticleIdList": ["10.1172/JCI117857", "PMC295707", "7535799"]}, {"Citation": "Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. cell. 1996;86(3):353\u2013364. 10.1016/S0092-8674(00)80108-7", "ArticleIdList": ["10.1016/S0092-8674(00)80108-7", "8756718"]}, {"Citation": "Efferth T, Li PC, Konkimalla VSB, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends in molecular medicine. 2007;13(8):353\u2013361. 10.1016/j.molmed.2007.07.001", "ArticleIdList": ["10.1016/j.molmed.2007.07.001", "17644431"]}, {"Citation": "Zhang X, Yu H. Matrine inhibits diethylnitrosamine-induced HCC proliferation in rats through inducing apoptosis via p53, Bax-dependent caspase-3 activation pathway and down-regulating MLCK overexpression. Iranian Journal of Pharmaceutical Research: IJPR. 2016;15(2):491", "ArticleIdList": ["PMC5018277", "27642320"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "25"}, {"Year": "2020", "Month": "7", "Day": "5"}, {"Year": "2020", "Month": "7", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["32730293", "PMC7392229", "10.1371/journal.pone.0236395", "PONE-D-20-11981"]}}]}